Correlazioni tra EMM/T, SOF, SPEA-C, PRTF1-2 e resistenza ai macrolidi in S.pyogenes

Autor: Ferranti, C, Tempera, Gianna, Bisignano, G, Furneri, Pio Maria

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4731::318aff9be28b2d478adda21ac80e54e0
http://hdl.handle.net/20.500.11769/95381

Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994-2006).

Autor: Rubio-López, Virginia¹ vi_ru_lo@hotmail.com, Valdezate, Sylvia¹, Álvarez, David¹, Villalón, Pilar¹, José Medina, María¹, Salcedo, Celia¹, Sáez-Nieto, Juan-Antonio¹

Publikováno v: BMC Microbiology. 2012, Vol. 12 Issue 1, p215-225. 11p. 2 Diagrams, 4 Charts.

Lipid-Based Formulation of Baricitinib for the Topical Treatment of Psoriasis.

Autor: Mohammadi-Meyabadi, Roya^1,2 (AUTHOR) rmohammo31@alumnes.ub.edu, Mallandrich, Mireia^1,2 (AUTHOR) mireia.mallandrich@ub.edu, Beirampour, Negar¹ (AUTHOR) jsuner@ub.edu, Garrós, Núria^1,2 (AUTHOR) anacalpena@ub.edu, Espinoza, Lupe Carolina³ (AUTHOR), Sosa, Lilian^4,5 (AUTHOR) mireia.mallandrich@ub.edu, Suñer-Carbó, Joaquim^1,2 (AUTHOR), Rodríguez-Lagunas, María José^6,7 (AUTHOR), Garduño-Ramírez, María Luisa⁸ (AUTHOR), Calpena-Campmany, Ana C.^1,2 (AUTHOR)

Publikováno v: Pharmaceutics. Oct2024, Vol. 16 Issue 10, p1287. 19p.

Association of JAK2 Haplotype GGCC_46/1 with the Response to Onco-Drug in MPNs Patients Positive for JAK2V617F Mutation.

Autor: Perrone, Michela^1,2 (AUTHOR) michela.perrone2@studenti.unisalento.it, Sergio, Sara^1,2 (AUTHOR) michele.maffia@unisalento.it, Tarantino, Amalia³ (AUTHOR) amalia.tarantino@asl.lecce.it, Loglisci, Giuseppina⁴ (AUTHOR) giuseppina.loglisci@asl.lecce.it, Matera, Rosella³ (AUTHOR) rosella.matera@asl.lecce.it, Seripa, Davide³ (AUTHOR) davide.seripa@asl.lecce.it, Maffia, Michele^1,2 (AUTHOR), Di Renzo, Nicola⁴ (AUTHOR) nicola.direnzo@asl.lecce.it

Publikováno v: Onco. Sep2024, Vol. 4 Issue 3, p241-256. 16p.

INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology.

Autor: Yue EW; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Sparks R; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Polam P; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Modi D; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Douty B; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Wayland B; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Glass B; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Takvorian A; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Glenn J; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Zhu W; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Bower M; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Liu X; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Leffet L; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Wang Q; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Bowman KJ; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Hansbury MJ; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Wei M; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Li Y; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Wynn R; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Burn TC; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Koblish HK; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Fridman JS; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Emm T; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Scherle PA; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Metcalf B; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States., Combs AP; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States.

Publikováno v: ACS medicinal chemistry letters [ACS Med Chem Lett] 2017 Mar 06; Vol. 8 (5), pp. 486-491. Date of Electronic Publication: 2017 Mar 06 (Print Publication: 2017).